Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Noigel is a Japanese biotechnology company specializing in advanced drug delivery systems (DDS) based on its proprietary temperature-responsive hydrogel technology. The company's core platform, also named Noigel, exists as a liquid at room temperature and transforms into a stable gel at body temperature, allowing for precise, localized, and sustained release of therapeutic agents. This technology is being applied to various medical needs, including the prevention of post-operative adhesions and the controlled delivery of proteins and small molecules. Noigel aims to improve patient outcomes by enhancing the efficacy and safety of existing and novel treatments through its innovative biomaterials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Noigel.